Sanifit

Sanifit raises USD 80.9 M to advance Calciphylaxis Pipeline Sanifit, a clinical-stage biopharmaceutical company, has raised USD 80.9 million ( €72.2 million ) in total private fundraising. The financing mainly consisted led by Spain’s Caixa Capital Risc, along with many new investors, including Columbus Venture ...

Did you know that Calciphylaxis, or calcific uremic arteriolopathy (CUA), although affects merely 1 to 4 % of patients undergoing dialysis, has a dismal prognosis with up to 80% mortality? In addition to numerous comorbidities which affect the majority of dialysis patients, Calciphylaxis is a painful and often fatal...